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Epithelial keratinocyte proliferation is an essential
element of wound repair, and abnormal epithelial
proliferation is an intrinsic element in the skin
disorder psoriasis. The factors that trigger epithelial
proliferation in these inflammatory processes are
incompletely understood. Here we have shown that
regenerating islet-derived protein 3-alpha (REG3A)
is highly expressed in keratinocytes during psoriasis
and wound repair and in imiquimod-induced psori-
atic skin lesions. The expression of REG3A by kerati-
nocytes is induced by interleukin-17 (IL-17) via acti-
vation of keratinocyte-encoded IL-17 receptor A
(IL-17RA) and feeds back on keratinocytes to inhibit
terminal differentiation and increase cell proliferation
by binding to exostosin-like 3 (EXTL3) followed by
activation of phosphatidylinositol 3 kinase (PI3K)
and the kinase AKT. These findings reveal that
REG3A, a secreted intestinal antimicrobial protein,
can promote skin keratinocyte proliferation and can
be induced by IL-17. This observation suggests
that REG3A may mediate the epidermal hyperprolif-
eration observed in normal wound repair and in
psoriasis.
INTRODUCTION
A well-controlled and coordinated balance between immune
defense and epithelial cell proliferation and differentiation is
essential to normal wound repair. Keratinocytes are the pre-
dominant epithelial cell in skin and execute several complex
processes that trigger inflammation as well as cell proliferation
to maintain the structure and function of the epidermis (Eckert
et al., 2002). After skin injury, the process of wound healing
requires keratinocytes at the wound edge to resist microbial74 Immunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc.invasion; keratinocytes also migrate and proliferate to enable
appropriate reepithelialization (Schauber et al., 2007; Gallo
et al., 1994). However, in some inflammatory diseases such
as psoriasis, an imbalance between proliferation and differenti-
ation of keratinocytes results in epidermal hyperproliferation
in excess of the extent of skin injury (Albanesi et al., 2007).
Products of inflammatory cells present in both wound repair
and psoriasis also contribute to the observed changes in
keratinocyte proliferation and differentiation. Specifically,
advances in understanding the pathophysiology of psoriasis
have shown that increased interleukin-17 (IL-17) and IL-22
contribute to the cycle of inflammation and cellular proliferation
that ultimately results in keratinocyte hyperproliferation and
lesion formation in psoriasis (Lande et al., 2007; Zheng et al.,
2007).
The cutaneous inflammatory response after injury includes
the release of several proinflammatory cytokines such as IL-6,
TNF-a, IL-17, and IL-22 (Finnerty et al., 2009; Lai et al., 2009).
Many of these molecules induce inflammation to resist infection
at the epithelial interface and stimulate wound repair. Other
molecules released during injury, such as antimicrobial peptides,
provide innate antimicrobial activity in wounds to resist infection
and also stimulate cell growth and angiogenesis (Gallo et al.,
1994). In skin, these pathways intersect at several levels. For
example, IL-22 and IL-17 enhance the expression of antimicro-
bial peptides S100A7 and S100A8 in keratinocytes (Liang
et al., 2006). Combined, these events provide a coordinated
repair and defense strategy for the epidermis. However, in the
skin disease psoriasis, the production of IL-17, IL-22, and antimi-
crobial peptides appears to also contribute to the pathophysi-
ology of the disease (Lande et al., 2007; Zheng et al., 2007).
Therefore, understanding the elements that participate in the
cutaneous wound process is critical for both normal homeo-
stasis and diagnosis or treatment of disease.
Other epithelial organs also employ strategies that combine
antimicrobial defense and epithelial proliferation. For instance,
IL-22 can augment the clonogenic potential of lung epithelial
cells and accelerate repair after lung injury. In the intestine,
regenerating islet-derived protein 3-alpha (REG3A), also
Figure 1. Psoriasis Patients and Imiquimod-
Induced Psoriatic Mouse Skin Have High
Abundance of REG3A or RegIIIg in Lesional
Skin
(A) Quantification of REG3A mRNA expression of
skin from normal, basal cell carcinomas, atopic
dermatitis, and psoriasis patients. N.D., not
detectable.
(B) Immunofluorescent staining of skin in normal
and psoriasis patients by REG3A antibody. Scale
bars represent 200 mm.
(C) Immunofluorescent staining of normal and
imiquimod-induced psoriatic mouse skin by
RegIIIg antibody. Scale bars represent 100 mm.
(D and E) Quantification of IL-17a and RegIIIg
mRNA expression of skin from normal and
imiquimod-induced psoriatic mouse ears or
backs. *p < 0.05, **p < 0.01; n.s., no significance.
p values were determined by one-way or two-way
ANOVA. Data are the means ± SEM.
See also Figure S1.
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REG3A Regulates Epidermal Hyperproliferationnamed heptocarcinoma-intestine-pancreas (HIP) or pancreatic
associated protein (PAP), functions as an antimicrobial protein
in control of the bacterial proliferation (Brandl et al., 2008;
Cash et al., 2006; Vaishnava et al., 2011). In addition to antimi-
crobial function, the expression of RegIIIg, a mouse homolog
of human REG3A, is increased after several tissue injuries,
such as mucosal damage (Pull et al., 2005) and liver injury
(Lieu et al., 2005), and has been suggested to influence tissue
regeneration. Although REG3A or RegIIIg in internal tissues has
been extensively investigated, a role of REG3A or RegIIIg in
skin biology is less clear.
Given that the processes of both wound repair and psoriasis
have a relative increase in IL-17 and a need for innate microbial
defense, we investigated whether REG3A or RegIIIg is ex-
pressed after skin injury and determine whether it has potential
functional relevance in this system. Our findings uncover a vital
component that appears to be inherent to cutaneous wound
repair and of potential importance to the pathogenesis of
psoriasis.
RESULTS
REG3A or RegIIIg Is Abundantly Expressed
in Epidermal Keratinocytes of Psoriasis Patients
and Imiquimod-Induced Psoriatic Skin Lesions
Psoriasis is a skin disease characterized by excessive epithelial
cell proliferation and enhanced antimicrobial defense (de Jongh
et al., 2005; Wolk et al., 2006). Because of previous sug-
gestions that REG3A influences tissue regeneration andImmunity 37, 7immune defense in the gut (Lieu et al.,
2005; Okamoto, 1999; Vaishnava et al.,
2011), we hypothesized that REG3A
may also be expressed in hyperpro-
liferative keratinocytes of psoriasis
patients. To explore the expression of
REG3A, we performed quantitative real-
time reverse transcriptase-polymerase
chain reaction (RT-PCR) on biopsiesfrom the skin of 18 psoriasis patients. Compared to normal
patients, REG3A mRNA was abundantly expressed in lesional
skin of psoriasis patients, but not in normal skin or the lesional
skin of patients with another form of skin inflammation (atopic
dermatitis) or dysregulated keratinocyte proliferation (basal
cell carcinomas) (Figure 1A). REG3A protein expression was
detectable by immunohistochemistry localized to epidermal
keratinocytes in psoriatic lesional skin, but not in the epidermis
of normal skin (Figure 1B) or the epidermis of several skin carci-
nomas (Figure S1A available online). Interestingly, there is
a large discrepancy of REG3A expression in nonlesional skin
of psoriasis between Japanese and American patients in Fig-
ure 1A: REG3A was significantly increased in Japanese nonle-
sional psoriatic skin but was completely undetectable in
American nonlesional samples (Figure S1B). To further confirm
that REG3A is related to the psoriatic phenotype, we evaluated
an imiquimod-induced psoriatic mouse model (Figure S1C) and
found that both mRNA and protein of RegIIIg were increased in
imiquimod-induced psoriatic ear or back skin (Figures 1C–1E).
These data demonstrate that REG3A or RegIIIg is highly ex-
pressed in hyperproliferative keratinocytes of psoriasis but
not universally expressed in normal skin or during other forms
of skin inflammation or hyperproliferation.
Skin Injury Increases Epidermal RegIIIg Expression
Psoriasis lesions can be triggered by physical injury to the skin
of susceptible patients with this disorder (the Koebner
response). We therefore next measured the expression of
REG3A or RegIIIg in keratinocytes during wound repair4–84, July 27, 2012 ª2012 Elsevier Inc. 75
Unwounded Wounded
RegIII
18s RNA
D
Wounded
R
e
g
II
I
m
R
N
A
 e
x
p
re
s
s
io
n
(f
o
ld
 c
h
a
n
g
e
)
Wounded
Re
gI
IIα
 
m
RN
A 
e
xp
re
ss
io
n
(f
o
ld
 c
h
a
n
g
e
)
Wounded
GAPDH
RegIII
kDa
16
36
A B C
WoundedUnwounded
E
g
g
g
Figure 2. Skin Injury Increases Epidermal
RegIIIg Expression
(A) The expression of RegIIIg mRNA of 2 mm skin
surrounding the wound edge 3 days after aseptic
injury.
(B and C) Quantification of RegIIIg and RegIIIa
expression of skin treated as in (A).
(D) Immunoblot of RegIIIg in skin extracts from
mouse wound edges.
(E) Immunofluorescent staining of skin in wild-type
mouse treated as in (A) by RegIIIg antibody. The
scale bars represent 50 mm. ***p < 0.001. p values
were determined by two-tailed t tests.
Data are the means ± SEM of six mice for each.
See also Figure S2.
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REG3A Regulates Epidermal Hyperproliferationresponses. To test this, we made aseptic, full-thickness inci-
sions on the back of wild-type mice as previous reported (Lai
et al., 2009). The expression of RegIIIg mRNA was dramatically
increased in the wound edge compared to normal skin (Figures
2A and 2B). Another mouse homolog of human REG3A, RegIIIa
was also markedly increased in wounded skin (Figure 2C).
Consistent with increased mRNA expression, the protein abun-
dance of RegIIIg was elevated in wounded skin compared to
normal mouse skin (Figure 2D). Similar to human psoriatic
epidermis, RegIIIg was abundantly expressed by keratinocytes
localized in hyperproliferative epidermis and hair follicle (Fig-
ure 2E). Taken together, these results demonstrate that skin
injury increases RegIIIg expression in epidermal and hair follicle
keratinocytes.
IL-17 Induces the Expression of REG3A or RegIIIg
in Primary Keratinocytes and Mouse Skin Wounds
IL-17 and IL-22 are elevated in psoriatic skin and during
wounding (Figures 1D, 1E, and S2A–S2C; Res et al., 2010;
Rizzo et al., 2011). IL-22 has been shown to directly induce
RegIIIg in colonic epithelia cells (Zheng et al., 2008), so we
next evaluated whether IL-17 or IL-22 could influence REG3A
or RegIIIg expression in keratinocytes. Neonatal human
epidermal keratinocytes (NHEKs) treated with a panel of cyto-
kines showed that IL-17A, but not several other factors
elevated in psoriasis and wounded skin, induced REG3A
expression in keratinocytes (Figure 3A). This induction was
dose dependent with the maximum induction observed at
1,000 ng ml1 of IL-17A (Figure 3B). Increased REG3A protein
was also observed by immunohistochemical analysis of NHEKs
treated with IL-17A (Figure 3C). Moreover, the induction of
REG3A by IL-17 was dependent on the activation of IL-17
receptor A (IL-17RA). Treatment of NHEKs with short hairpin
RNAs (shRNAs) targeted to IL-17RA was effective in inhibiting
IL-17A-induced REG3A expression (Figure 3D). Moreover,
murine IL-17a and the supernatant of wounded skin homoge-
nate significantly increased RegIIIg expression in primary
murine epidermal keratinocytes, but this induction was
completely abrogated by mouse IL-17a-neutralizing antibody
(Figure 3E). In addition, the administration of IL-17a-neutralizing76 Immunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc.antibody into mouse back skin decreased both mRNA and
protein of RegIIIg in wounds (Figures 3F and 3G). Il17/
mice also showed significantly decreased RegIIIg expression
in skin wounds compared to control mice (Figure 3H). All these
data suggest that IL-17 is an important molecule from wounded
skin to induce REG3A or RegIIIg.
Unlike the previously reported role of IL-22 in induction of
RegIIIg in colonic epithelia (Zheng et al., 2008), IL-22 by itself
did not induce REG3A in keratinocytes (Figure 3A). Interestingly,
the combination of various doses of IL-22 with 600 ng ml1 of
IL-17A induced a further increase in REG3A (Figure S3A).
Although the receptor for advanced glycation endproducts
(RAGE) is involved in S100A family protein expression induced
by IL-17A and/or IL-22 (Heo et al., 2011), the cooperation of IL-
17A and IL-22 in induction of REG3A was not dependent
on this receptor, as shown by the fact that the treatment of
NHEKs with shRNAs targeted to RAGEwas effective in inhibiting
the expression of IL-17A-induced or IL-17A+IL-22-induced
S100A7, but not in IL-17A-induced or IL-17A+IL-22-induced
REG3A expression (Figures S3B and S3C). Thus, these data
show that IL-17A, rather than IL-22, activates its receptor IL-
17RA to directly induce REG3A in skin keratinocytes, whereas
IL-22 cooperatively increases REG3A in combination with
IL-17A.
REG3A Increases Keratinocyte Proliferation
via the Inhibition of Differentiation Genes
Because REG3A or RegIIIg is increased in hyperproliferative
keratinocytes in psoriasis (Figures 1B and 1C) and skin wounds
(Figure 2E), we next investigated whether REG3Awas involved in
the regulation of keratinocyte proliferation and differentiation.
When undifferentiated cultured NHEKs were exposed to re-
combinant REG3A, increased proliferation was observed as
detected by an increase in cell number and percentage of cells
observed in S phase (Figures 4A and 4B). Furthermore, we
observed that REG3A dramatically inhibited the expression of
the terminal differentiation marker genes keratin-10 (KRT10),
filaggrin (FLG), and loricrin (LOR) but not differentiation gene
keratin-5 (KRT5) (Candi et al., 2005) in cultured undifferentiated
NHEKs (Figure 4C).
Figure 3. IL-17 Activates IL-17RA to Induce REG3A or RegIIIg Expression in Primary Keratinocytes and Skin Adjacent to Wound Edge
(A) Quantification of REG3A mRNA expression in undifferentiated NHEKs stimulated by different cytokines.
(B) The expression of REG3A mRNA induced by the indicated doses of IL-17A.
(C) Immunofluorescent staining of undifferentiated NHEKs treated with 1,000 ng ml1 IL-17A by REG3A antibody. Scale bars represent 100 mm.
(D) The expression of REG3A after IL-17RA was silenced.
(E) RegIIIg expression in undifferentiated primary murine keratinocytes stimulated by the supernatant of skin wound homogenate pretreated with control IgG or
IL-17a-neutralizing antibody.
(F) RegIIIg expression in mouse skin wounds after IL-17a was neutralized by IL-17a-neutralizing antibody.
(G) Immunofluorescent staining of skin in wild-type mouse treated as in (F) by RegIIIg antibody. The scale bars represent 100 mm.
(H) RegIIIg expression in skin wounds of Il17/ and wild-type mice.
*p < 0.05, **p < 0.01, ***p < 0.001. p values were analyzed by two-tailed t test or one-way ANOVA. Data are the means ± SEM of n = 3. See also Figure S3.
Immunity
REG3A Regulates Epidermal HyperproliferationFurthermore, REG3A could inhibit keratinocyte differentiation
triggered by elevated extracellular calcium, a potent signal of
terminal differentiation that corresponds with increased Ca2+
present in the superficial epidermis. NHEKs were treated with
1.6 mM CaCl2 in the presence or absence of recombinant
REG3A. After 24 hr, a decreased cell number was observed
in high calcium conditions (Figure 4D) and a decreased
percentage of cells was observed in S phase (Figure 4E). In
contrast, REG3A increased cell number even in high calcium
(Figure 4D) and also rescued cells back to S phase (Figure 4E).
Moreover, the calcium-induced increased expression of loricrin
and filaggrin in keratinocytes was significantly inhibited by
REG3A (Figures 4F and 4G). All these data suggest that
REG3A can both increase keratinocyte proliferation and inhibit
differentiation, elements characteristic of psoriasis and normal
wound repair.REG3A Promotes Wound Reepithelialization
and Psoriatic Hyperproliferation
In response to epidermal injury, keratinocytes at the wound edge
withdraw from terminal differentiation and undergo changes in
gene expression followed by proliferation and migration (Epstein
et al., 1983; Patel et al., 2006). We have observed that the
amount of the terminal differentiation gene loricrin in wounded
skin was significantly less than that in normal skin in vivo (Fig-
ure S4A) and REG3A inhibited the expression of loricrin and
filaggerin in vitro (Figures 4C, 4F, and 4G). Therefore, the
capacity of REG3A to inhibit keratinocyte terminal differentiation
may promote cutaneous wound healing. To test this hypothesis,
we first conducted an in vitro wound scratch assay. Recombi-
nant REG3A increased the ability of both undifferentiated and
differentiated keratinocytes to migrate and reepithelialize
a defined cell-free area (Figures 5A–5C). Furthermore, theImmunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc. 77
Figure 4. REG3A Increases Keratinocyte Proliferation via the Inhibition of Differentiation Gene Expression
(A) REG3A induced undifferentiated NHEK proliferation analyzed by MTT.
(B) Undifferentiated keratinocytes in S phase by flow cytometry. The percentage of cells in S phase increased by REG3A was calculated by the amount of cells in
S phase at each indicated concentration divided by the amount of total cells.
(C) Quantification of differentiated gene expression in undifferentiated NHEKs.
(D) Cell number after NHEKs were treated with 0.1 nM REG3A and/or 1.6 mM CaCl2.
(E) Differentiated keratinocytes back into S phase induced by REG3A.
(F and G) CaCl2-induced loricrin (LOR) and filaggrin (FLG) expression in the presence or absence of REG3A.
*p < 0.05, **p < 0.01, ***p < 0.001; n.s., no significance. p values were analyzed by one-way or two-way ANOVA. Data are the means ± SEM of n = 3.
Immunity
REG3A Regulates Epidermal Hyperproliferationoverexpression of REG3A in undifferentiated keratinocytes
accelerated wound reepithelialization (Figures S4B and S4C).
In addition, IL-17A enhanced in vitro wound reepithelialization
via the induction of REG3A as IL-17A lost its capacity to promote
keratinocyte reepithelialization after REG3A was silenced
(Figure S4D).
After in vitro wound scratch model, we next confirmed the role
of RegIIIg in promoting wound healing and psoriatic hyperprolif-
eration in vivo. RegIIIg significantly accelerated skin wound
healing after 100 mg of RegIIIg was intradermally injected into
mouse back skin before wounding (Figure 5D), but the blockade
of IL-17a or RegIIIg by IL-17a- or RegIIIg-neutralizing antibody,
respectively, significantly delayed the healing process at day 3
(Figure 5E). However, the administration of recombinant RegIIIg
before IL-17a blockage could restore this event (Figure 5E). In
addition to delaying wound healing, RegIIIg blockage decreased
ear thickness and epidermal hyperproliferation induced by imi-
quimod (Figures 5F and 5G). Thus, these findings confirmed78 Immunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc.that REG3A or RegIIIg inhibited keratinocyte differentiation to
promote wound reepithelialization or to induce psoriatic
epidermal hyperproliferation.
REG3A Activates EXTL3-PI3K-AKT Signaling Pathway
to Regulate Keratinocyte Differentiation
Having established the involvement of REG3A in the regulation of
keratinocyte differentiation and the role of REG3A in promoting
wound healing, we next sought to explore the mechanism by
which keratinocytes respond to REG3A. Exostosin-like 3
(EXTL3) has been implicated as a binding protein for REG1 in
pancreatic b cell (Kobayashi et al., 2000) and as a potential
receptor for HIP in pancreatic carcinoma cell line (Levetan
et al., 2008). We thereby evaluated whether EXTL3 is required
for the function of REG3A in keratinocytes. EXTL3 was observed
to be expressed in keratinocytes (Figures S5A and S5B) and
treatment with REG3A further increased its expression (Fig-
ure S5B). REG3A bound to EXTL3 on keratinocytes as
Time (days)
Normal
Imiq+IgG
Imiq+RegIII Ab
Ea
r t
hi
ck
n
es
s 
(m
m) Control Imiqui Imiqui + Reg Ab
RegIII
Control
H
ea
lin
g 
a
re
a
 (%
)
Time (days)
Control RegIII
day0
day4
day10
D
RegIII
IL-17 Ab
H
ea
lin
g 
a
re
a
 (%
)
n.s.
RegIII Ab
E
F
G
H
ea
lin
g 
a
re
a
 (%
)
REG3A(0.00nM)
REG3A(0.03nM)He
al
in
g 
a
re
a
 (%
)
Time (hr)
A B
Time (hr)
Control
Ca2+
Ca2+ + REG3A
C Control Ca2+ REG3A +Ca2+
Figure 5. REG3A or RegIIIg Promotes
Wound Reepithelialization and Psoriatic
Hyperproliferation
(A) Percentage of scratch wound healing of
undifferentiated NHEKs.
(B) Percentage of scratch wound healing of
differentiated NHEKs.
(C) Identical fields treated as in (B) at 0 and 24 hr
scratch. The yellow dotted line represents the area
of the scratch at t = 0 hr. The green dotted line
represents the area of the scratch at t = 24 hr.
(D) RegIIIg promoted wound healing in vivo.
(E) Wound healing at day 3 after IL-17a or RegIIIg
blockage.
(F) Imiquimod-induced ear thickness with or
without RegIIIg blockage.
(G) Imiquimod-induced epidermal hyperpro-
liferation with or without RegIIIg blockage. Scale
bars represent 100 mm.
*p < 0.05, **p < 0.01, ***p < 0.001; n.s., no signifi-
cance. p values were determined by one-way or
two-way ANOVA. Data are represented as the
mean ± SEM of n = 3–6. See also Figure S4.
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REG3A Regulates Epidermal Hyperproliferationdemonstrated by immunoprecipitation of REG3A-treated kerati-
nocytes with REG3A antibody and detection with antibody to
EXTL3, or when EXTL3 was precipitated and REG3A antibody
was used for detection (Figure 6A). Silencing of EXTL3 signifi-
cantly blocked the inhibitory effect of REG3A on differentiation
as detected by the expression of loricrin in NHEKs (Figures 6B
and S5C), and the administration of EXTL3 antibody into mouse
back skin in vivo abrogated the inhibitory effects of RegIIIg on
both mRNA and protein of loricrin in wounds (Figures 6C and
6D). Silencing of EXTL3 also inhibited the capacity of REG3A
to increase cell proliferation (Figure 6E). However, although
mannose receptor c-type 1 (MRC1) is a known receptor for C-
type lectins and REG3A belongs to C-type lectin family, silencing
of MRC1 did not change the expression of loricrin (Figures S5D
and S5E). Furthermore, although EXTL3 can influence heparan
sulfate synthesis (Busse et al., 2007; Norton et al., 2005), the
effect of silencing of EXTL3 didn’t appear to be due to the
influence of this gene on proliferation induced by heparin binding
growth factors (Radek et al., 2009; Trowbridge et al., 2002)Immunity 37, 7because EXTL3 silencing did not
decrease in vitro wound reepithelializa-
tion induced by fibroblast growth factor
7 (FGF7) (Figure S5F) but did decrease
REG3A-induced wound reepithelializa-
tion (Figure 6F). These data suggest
that REG3A acts through EXTL3 ex-
pressed by keratinocytes and not through
a dependence on the glycosyltransferase
activity of EXTL3.
The finding of a functional REG3A
receptor on keratinocytes compelled
us to further explore EXTL3-activated
downstream signaling pathways. Multiple
pathways have been reported to regulate
the proliferation and/or differentiation
of keratinocytes, including mitogen-acti-vated protein kinase (MAPK) andWnt signaling pathways (Croyle
et al., 2011; Yu et al., 2009). We thereby used inhibitors of those
pathways to treat undifferentiated NHEKs in the presence or
absence of REG3A. Among these inhibitors, phosphatidylinositol
3 kinases (PI3K) inhibitors wortmannin and Ly294002 signifi-
cantly blocked the inhibitory effect of REG3A on loricrin expres-
sion (Figures 7A and 7B), but this was not blocked by MAPK
inhibitor SB202190 and Wnt inhibitor DKK1 (data not shown).
Wortmannin also inhibited keratinocyte proliferation induced by
REG3A (Figure 7C). In contrast to RegIIIg, wortmannin increased
loricrin expression (Figure 7D) and delayed the healing of skin
wounds in vivo (Figure 7E). It is known that the activation of
PI3K induces the phosphorylation of AKT. To confirm that PI3K
is the downstream signal molecule for EXTL3, we next checked
whether REG3A activated PI3K to induce AKT phosphorylation
after EXTL3 was silenced. REG3A markedly increased the
phosphorylation of AKT (Figures 7F and 7G) and this increase
was inhibited after EXTL3was silenced (Figure 7F). Furthermore,
the phophorylated AKT by REG3A was decreased after PI3K4–84, July 27, 2012 ª2012 Elsevier Inc. 79
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Figure 6. EXTL3 Is Required for REG3A Activation in Keratinocytes
(A) REG3A bound to EXTL3 in human keratinocytes.
(B) Loricrin expression induced by REG3A after EXTL3 was silenced.
(C) Immunofluorescent staining of skin by loricrin antibody after EXTL3 blockage. The scale bars represent 100 mm.
(D) Loricrin expression in mouse wounded skin treated as in (C).
(E and F) Cell proliferation and wound healing induced by REG3A after EXTL3 was silenced.
*p < 0.05, **p < 0.01, ***p < 0.001; n.s., no significance. p values were determined by one-way ANOVA. Data are means ± SEM of n = 3. See also Figure S5.
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REG3A Regulates Epidermal Hyperproliferationwas inhibited by wortmannin (Figure 7G). All these data suggest
that REG3A activates EXTL3-PI3K-AKT signaling pathway to
regulate keratinocyte proliferation and/or differentiation.
DISCUSSION
Proliferation and/or differentiation of keratinocytes is essential
for the process of wound repair and is dysregulated in the skin
disease psoriasis. REG3A or RegIIIg has been proposed to
regulate cell proliferation or differentiation after mucosal damage
(Pull et al., 2005) and liver injury (Lieu et al., 2005) but was not
known to be involved in skin homeostasis. Here we observed
that REG3A or RegIIIg may modulate epidermal repair through
control of keratinocyte proliferation and differentiation. Our
results revealed that REG3A or RegIIIg is induced by IL-17,
a prominent cytokine abundant in psoriasis, thus suggesting
this as a link between IL-17-mediated inflammation and skin
proliferation. The mechanism for REG3A-mediated proliferation
involves inhibition of differentiation through the binding to its
receptor EXTL3, followed by the activation of PI3K and AKT,
events that we show have a major role in promoting wound re-
epithelialization. Overexpression of REG3A in keratinocytes,
possibly as a consequence of excess IL-17 and/or IL-22, may
therefore lead to the epidermal hyperproliferation seen in
psoriasis after skin trauma. Thus, the identification of REG3A
as a stimulus for keratinocyte proliferation, and the elucidation80 Immunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc.of its mechanism of action, provides crucial information for
understanding epidermal homeostasis, repair, and disease.
These findings also offer potential targets for therapy.
Wounding breaches the intact physical and chemical cuta-
neous barrier against the outer environment. To reestablish an
effective physical barrier, keratinocytes from the wound edge
begin to migrate and reepithelialize the injury (Schauber et al.,
2007). Previously, REG3A or RegIIIgwas undetectable in normal
skin (Choi et al., 2007; Drognitz et al., 2006; Ogawa et al., 2003;
Syder et al., 2003), but we show that acute wounding dramati-
cally increased RegIIIg expression in keratinocytes around the
wound edge. However, despite lack of an acute injury, REG3A
or RegIIIg was also observed to be abundantly expressed in le-
sional skin of psoriasis patients or imiquimod-induced psoriatic
mouse skin. The effects of REG3A or RegIIIg on keratinocyte
proliferation and its capacity to inhibit terminal differentiation
link this system to essential processes involved in homeostasis
of the skin and suggest that this could be a marker for skin injury
and a potential prognostic indicator of psoriasis severity.
Multiple factors including cytokines, enzymes, and growth
factors are involved in the initiation of the complex process of
repair. Recently, IL-17A and IL-22 have been reported tomediate
IL-23-induced hyperplasia of epidermis through the activation of
signal transduction and activators of transcription 3 (STAT3)
in vivo (Zheng et al., 2007) and IL-22 induces keratinocyte
migration via downregulation of a set of differentiation-related
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Figure 7. REG3A or RegIIIg Activates PI3K-AKT Signaling Pathway to Regulate Keratinocyte Differentiation
(A and B) Loricrin expression of NHEKs treated with REG3A and/or inhibitors wortmannin and Ly294002.
(C) The proliferation of NHEKs treated as in (A).
(D) Loricrin in wounds of mice treated with RegIIIg or wortmannin.
(E) Wound healing of mice treated with wortmannin.
(F) Phosphorylation of AKT after NHEKs were treated REG3A and/or EXTL3 shRNA.
(G) Phosphorylation of AKT of NHEKs treated with REG3A and/or wortmannin.
*p < 0.05, **p < 0.01, ***p < 0.001; n.s., no significance. p values were determined by one-way ANOVA or two-way ANOVA. Data are the means ± SEM of n = 3.
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REG3A Regulates Epidermal Hyperproliferationgenes in vitro (Boniface et al., 2005). However, whether IL-17
and/or IL-22 directly regulate keratinocyte proliferation and
differentiation is unknown. Here we show that IL-17 induced
REG3A or RegIIIg through the activation of IL-17RA to mediate
cell proliferation. Furthermore, IL-22 cooperatively increased
this to inhibit keratinocyte differentiation after skin injury,
revealing that REG3A or RegIIIg can be the link among IL-17,
IL-22, and keratinocyte proliferation and/or differentiation.
Because STAT3 is a downstream signal molecule for IL-22 to
induce RegIIIg in colonic epithelial cells, it remains to be deter-
mined whether the activation of STAT3 by IL-17 is required for
REG3A expression in keratinocytes. Furthermore, the mecha-
nism of cooperation between IL-17 and IL-22 in regulation of
REG3A needs further investigation. One speculation is that
IL-22-induced STAT3 signaling converges with the NF-kB
pathway to cooperate with IL-17 in REG3A induction. However,
it is possible that this cooperation occurs at the level of down-
stream kinases that have been implicated in both IL-22R and
IL-17R signaling, including MAPK and JUN N-terminal kinases
(Kolls et al., 2008). REG3A might be an intermediate in this cyto-
kine-regulated commitment to keratinocyte proliferation and/or
differentiation as indicated by the paradigm of the crosstalk
between epithelial cells and IL-17-expressing cells.
IL-17 is a potent proinflammatory mediator and is associated
with several inflammatory diseases, including rheumatoid
arthritis, systemic lupus erythematosus, multiple sclerosis, and
asthma (Dong, 2006; Infante-Duarte et al., 2000; Langrish
et al., 2005). Increasing evidence also shows that IL-17 partici-
pates in the pathogenesis of certain skin disorders, in particular
psoriasis. IL-17 in synergy with IL-22 can induce critical eventsof psoriasis, including STAT3 activation and antimicrobial
peptide elaboration (Tokura et al., 2010). Our results clarify the
role of IL-17 in the context of IL-17-expressing-cell-dependent
chronic inflammation in psoriasis and reveal that IL-17 induces
REG3A to directly mediate keratinocyte differentiation in
psoriasis, suggesting the important role of IL-17 and REG3A in
hyperplasia of epidermis. Furthermore, this finding of REG3A
as a downstream target of IL-17 has the potential to improve
psoriasis therapy because current therapy in psoriasis that
targets IL-17 results in systemic immunosuppression.
Although it was known that REG3A can mediate tissue regen-
eration, the underlying mechanism by which REG3A regulates
cell proliferation and differentiation had been poorly explored.
Here we show that REG3A depends on EXTL3 and activates
PI3K and Akt to inhibit differentiation in keratinocytes. EXTL3
has been suggested to be a receptor of REG proteins (Kobayashi
et al., 2000; Levetan et al., 2008), but its downstream mediator
had not been previously reported. We used shRNA interference
and immunoprecipitation to confirm the functional association
between REG3A and EXTL3 followed by screening of its down-
stream mediators PI3K and AKT by using inhibitors for several
pathways. Furthermore, even though EXTL3 is thought to be
involved in heparan sulfate chain elongation, and heparan sulfate
is required for FGF signaling (Radek et al., 2009; Trowbridge
et al., 2002; Busse et al., 2007; Norton et al., 2005), silencing
of EXTL3 did not change the expression of syndecan-1 (data
not shown) and did not inhibit the function of a heparan
sulfate-depended growth factor, FGF7. These results suggest
that EXTL3 silencing does not exert its effect on REG3A by
an alteration of proteoglycan synthesis mediated by theImmunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc. 81
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REG3A Regulates Epidermal Hyperproliferationglycosyltransferase activity of the EXT family of genes. However,
further study is needed of the role of glycosaminoglycan
synthesis and whether other signaling pathways as well as the
EXTL3-PI3K-AKT pathway are involved in the REG3A response.
In conclusion, these findings support our discovery that
REG3A or RegIIIg is important for keratinocyte proliferation
and/or differentiation after skin injury. Induction of REG3A or
RegIIIg is critical for wound reepithelialization and might be
a previously unknown key element in the pathogenesis of
psoriasis. Our findings implicate the potential of REG3A or
RegIIIg as a therapeutic target in psoriasis and wound healing.
The identification of REG3A function in skin provides insights
into pathways contributing to antimicrobial defense, wound
repair, and psoriasis andmay ultimately lead to the development
of different forms of treatment.
EXPERIMENTAL PROCEDURES
Patients
All skin samples were obtained from 18 psoriasis patients (7 American and
11 Japanese; mild to plaque-type psoriasis and not on current treatment),
7 atopic dermatitis patients, 26 basal cell carcinomas, or 2–3 actinic keratosis,
bowen disease, seborrheic keratosis, and malignant melanoma with a 2-mm
punch biopsy. 2-mm punch biopsy from 13 normal patients (5 American and
8 Japanese) was used as control. All these samples were used for RNA
isolation or OCT section. The data of REG3A expression from lesional and
nonlesional skin of psoriasis patients were analyzed as follows: 7 American
psoriasis samples were normalized to 5 American normal patients and 11
Japanese psoriasis samples were normalized to 8 Japanese normal patients,
and REG3A expression in lesional skin was the combination of 7 American and
11 Japanese psoriasis patients. All sample acquisitions, including skin biop-
sies, were approved by the Human Research Protection Program at the
University of California, San Diego, and the ethical committee of the Catholic
University of Korea, and performed in accordance with the declaration of
Helsinki Principles. Informed consent was obtained for all procedures.
Mice
Mice were housed in VA San Diego Healthcare System VeterinaryMedical Unit
(VMU) and the animal facilities in Loyola University Chicago and East China
Normal University. Il17/ mice were purchased from Y. Iwakura’s lab in
University of Tokyo. All animal experiments were approved by VA San Diego
Healthcare System, Loyola University Chicago IACUC committee, and East
China Normal University Animal Care and Use Committee.
Cellular Proliferation
Neonatal human epidermal keratinocytes (NHEKs, Cascade Biologics) were
cultured as previous reported (Lai et al., 2009). The indicated doses of
recombinant REG3A purchased from Novus Biologicals or purified by our
laboratory were used to stimulate NHEKs. After stimulation, cells were sent
to the flow cytometry core in the Institute of Biomedical Sciences in East China
Normal University to evaluate cell cycle. The cells’ entry into S phase were
counted as proliferative cells. In addition to FACS, MTT assay (Amresco)
performed according to manufacturer’s instruction was used to evaluate cell
proliferation induced by REG3A.
shRNA Preparation and Targeting Gene Knockdown
Oligonucleotides encoding human REG3A, EXTL3, IL-17RA, and RAGE
shRNA (Table S1) were designed. Blast search was performed with the
National Center for Biotechnology Information (NCBI) database to ensure
that the shRNA constructs were targeting only human REG3A, EXTL3, IL-
17RA, or RAGE. The oligonucleotides were annealed and cloned into the
pLL3.7 vector as the manufacturer described. 4 mg of pLL3.7 constructs
containing shRNAs, 4 mg of packaging plasmid psPAX2 (Addgene), and 2 mg
of envelope plasmid pMD2.G (Addgene) were used to transfected HEK293T
cells by calcium phosphate precipitation method. 48 hr later, lentiviruses82 Immunity 37, 74–84, July 27, 2012 ª2012 Elsevier Inc.containing targeted gene shRNA were collected and used to transfect NHEK
cells.
Real-Time Quantitative RT-PCR
Real-time RT-PCR-specific primers as shown in Table S2 were used to
evaluate gene expression. RNA analysis was done as previously reported
(Lai et al., 2009).
Cutaneous Injury In Vivo
The back skin of mice was wounded by biopsy punches as previously
described (Nizet et al., 2001). 3 days later, RNA or protein from 2 mm of
skin around wound edges was collected either for real-time RT-PCR or immu-
noblot. Or the wounded skin was stored in OCT (Leica) or paraffin (Shanghai
Sanjing Gongmao Ltd. Co) for immunhistochemical analysis.
Immunoprecipitation, Immunoblotting, and Immunohistochemistry
2 mm mouse skin taken from mouse wound edge or cells treated with REG3A
or EXTL3 shRNAs or wortmannin (Sigma) was lysed with RIPA buffer (pH 7.4)
containing protease inhibitor cocktail (Roche). 15 mg of total protein was used
for immunoprecipitation and 5 mg of total protein was used for immunoblot.
RegIIIg was detected by immunoblot with RegIIIg antibody that was gifted
by L.V. Hooper from the University of Texas Southwestern Medical Center at
Dallas. AKT and EXTL3 were detected by immunoblot with AKT antibody
(Cell Signaling) and monoclonal EXTL3 antibody (Santa Cruz).
4 mm of formalin-fixed, paraffin-embedded tissue sections was mounted on
glass slides and used for immunohistochemistry and staining. 2% PFA was
used to fixate the samples. After 10 min fixation and subsequent pretreated
with antigen retrieval solution, the sections were stained with REG3A antibody
that was developed by our group or loricrin-specific antibody (Santa Cruz). The
sections were reprobed with rabbit IgG FITC conjugate antibody (Sigma) or
goat IgG FITC conjugate antibody (Jackson Immunoresearch Laboratories)
and then mounted in ProLong Gold antifade reagent with DAPI (Invitrogen)
and visualized by the microscope (Leica).
Wound Healing
In Vitro Keratinocyte Wound
The capacity of NHEKs to migrate, proliferate, and close a defined area of
injury to a confluent monolayer in vitro was evaluated by modification of a
previously reported assay (Cha et al., 1996; Radek et al., 2009). In brief, before
wounding NHEKs were transfected with REG3A overexpression vectors by
lipofectmin 2000 (Invitrogen) or REG3A shRNAs, EXTL3 shRNAs by calcium
phosphate precipitation. Cells were then scratched once per well vertically
with a P1000 pipette tip to create an artificial wound. After being washed twice
to remove cellular debris by PBS, cells were treated with 0.01 nM and 0.03 nM
recombinant REG3A in the presence or absence of 1.6 mM CaCl2 or 3 nM
FGF7. PBS was used as a negative control (untreated cells). The same fields
were photographed every 12 hr and the area migrated by keratinocytes was
calculatedwith Image-pro Plus 6.0 (Media Cybernetics). The percentmigration
at indicated time point was calculated by subtracting the total area of the
scratch at corresponding time point from the total area of the scratch at
0 hr, divided by the total area at 0 hr multiplied by 100.
In Vivo Wound Healing
100 mg of RegIIIg or 12.5 mg of wortmannin (Calbiochem) was intradermally in-
jected into mouse back skin or 100 mg of monoclonal mouse IL-17a or RegIIIg
antibody was i.p. injected 1 day before 100 mg of RegIIIg injection. 4 hr later,
wounds were made by 8 mm biopsy punches and photographed every day.
The healing area was calculated by Image J. The percent of healing area at
indicated time point was calculated by subtracting the total area of wounds
at corresponding time point from the total area of wounds at 0 day, divided
by the total area at 0 day multiplied by 100.
Imiquimod Model of Skin Inflammation
10-week-old BALB/C mice were given 50 mg of imiquimod (InvivoGen) in the
shaved back and 25 mg of imiquimod in right ear daily for 5 days as previous
described (Ramirez-Carrozzi et al., 2011). For RegIIIg blockage, 100 mg of
RegIIIg antibody was i.p. injected 1 day before 25 mg of imiquimod was used
to induce psoriatic skin. Ear thickness was measured every day. On day 5,
Immunity
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tochemical evaluation or RegIIIg and IL-17a mRNA analysis.
IL-17a or EXTL3 Neutralization
In Vitro IL-17a Neutralization
Primary murine keratinocytes were isolated from 3-day-old neonates and
cultured under standard culture conditions. 175 mg of total protein of 3-day
wound homogenates was incubated with final concentration of monoclonal
mouse IL-17a antibody (R&D) at 0.1 mg ml1 for 30 min. Supernatants pre-
treated with or without IL-17a antibody were then used to stimulate primary
murine keratinocytes for 24 hr. RNA was isolated for analyzing RegIIIg
expression.
In Vivo IL-17a or EXTL3 Neutralization
100 mg of monoclonal mouse IL-17a antibody (R&D) or 10 mg of EXTL3
antibody (Santa Cruz) was intradermally injected into mouse back skin 24 hr
and 4 hr before wounding. 3 days later, 2 mm skin around mouse wounds
was taken for immunohistochemistry and analysis of RegIIIg or loricrin
expression.
Statistical Analysis
All data are present as mean ± SEM. We used two-tailed t tests to determine
significances between two groups.We did analyses of multiple groups by one-
way or two-way ANOVA with Bonferroni post test of GraphPad Prism Version
5. For all statistical tests, we considered p values <0.05 to be statistically
significant.
SUPPLEMENTAL INFORMATION
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